Drug Developement/Delivery
- FGF21 agonist for MASH: Current Status
- In Vivo CAR-T Delivery: mRNA-LNP System
- Next-Generation mRNA-LNPs: Strategies to Reduce Anti-PEG Antibody Responses
- CD388, a Novel Drug Fc-Conjugate (DFC) to Prevent Influenza Infection
- FDA Approves Palopegteriparatide for Hypoparathyroidism
- Radionuclide Drug Conjugates (RDCs): Current Status
- ADC in Combination with PD-1: Approvals and Clinical Trials
- ROR1 ADCs in Clinical Trials: MK-2140, NBE-002 & CS5001
- Trophoblast Glycoprotein (TPGB/5T4): A New Target For ADC Drugs
- Summary of ADC Targets For Solid Tumors & Hematological Tumors